DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Research

• Publication date

  1994-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8313378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

  1993cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters.

  1993cited by this paper
• Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Induction of cellular p53 activity by DNA-damaging agents and growth arrest

  1993influential reference
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Sequence‐specific DNA binding by p53: identification of target sites and lack of binding to p53 ‐ MDM2 complexes.

  1993cited by this paper
• Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

  1993cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992influential reference
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• The p53 tumour suppressor gene

  1991influential reference
• Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.

  1991cited by this paper
• Identification of p53 as a sequence-specific DNA-binding protein

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991influential reference
• Ca2+ is essential for multistep activation of the heat shock factor in permeabilized cells

  1991cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis.

  1977cited by this paper

• Effect of pharmacodynamical interaction between nutlin-3a and aspirin in the activation of p53.

  2021cites this paper
• Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment.

  2019cites this paper
• Involvement of Parp1 in the downstream of p53 dependent signaling pathway induced after gamma-irradiation

  2018cites this paper
• p53-dependent cell cycle checkpoint after DNA damage and its relevance to PARP1

  2018cites this paper
• CPUY201112, a novel synthetic small-molecule compound and inhibitor of heat shock protein Hsp90, induces p53-mediated apoptosis in MCF-7 cells

  2016cites this paper
• Association of genetic polymorphisms in GADD45A, MDM2, and p14 ARF with the risk of chronic benzene poisoning in a Chinese occupational population.

  2009influential citation
• Multiple modes of Mdmx regulation affect p53 activation

  2008cites this paper
• p53 and MDM2 expression in odontogenic cysts and tumours.

  2008cites this paper
• Minireview Mdm 2 : The Ups and Downs

  2007cites this paper
• Role of MDM2 In Cell Growth Regulation

  2006cites this paper
• Alleviation of benzo[a]pyrene-diolepoxide-DNA damage in human lung carcinoma by glutathione S-transferase M2.

  2005cites this paper
• Regulation of Transcriptional Activation of mdm 2 Gene by p 53 in Response to UV Radiation 1

  2005cites this paper
• Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines

  2005cites this paper
• Flow cytometric analysis of MDM2-mediated growth arrest.

  2003cites this paper
• Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations.

  2003cites this paper
• Cell cycle regulatory functions of the human oncoprotein MDM2.

  2003cites this paper
• Redox Control of Cell Death

  2002cites this paper
• Abnormal Expression of the p 53-Binding Protein MDM 2 in Hodgkin ' s Disease

  2002cites this paper
• Function and dysfunction of the human oncoprotein MDM2.

  2002cites this paper
• p53: an overview of over two decades of study.

  2001cites this paper
• Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.

  2000cites this paper
• Multiple signaling pathways involving ATM.

  2000cites this paper
• Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells

  2000cites this paper
• MDM2 oncogene as a novel target for human cancer therapy.

  2000cites this paper
• DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms*

  2000cites this paper
• Absence of p53-mediated G1 arrest with induction of MDM2 in sterigmatocystin-treated cells.

  2000cites this paper
• Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer

  2000cites this paper
• Alteration of G1 cell‐cycle protein expression and induction of p53 but not p21/waf1 by the DNA‐modifying carcinogen 2‐acetylaminofluorene in growth‐stimulated hepatocytes in vitro

  1999cites this paper
• Involvement of Heat‐Shock Protein 70 and P53 Proteins in Attenuation of UVC‐lnduced Apoptosis by Thermal Stress in Hepatocellular Carcinoma Cells

  1999cites this paper
• Mdm2: The Ups and Downs

  1999cites this paper
• New insights into p53 protein stabilisation in oral squamous cell carcinoma.

  1999cites this paper
• Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation.

  1998cites this paper
• Review : p53 in the pathogenesis, diagnosis, and treatment of cancer

  1998cites this paper
• DNA Damage and Repair

  1998cites this paper
• Increased Mdm2 Expression in Rat Brain after Transient Middle Cerebral Artery Occlusion

  1998cites this paper
• Transcriptional Responses to Damage Created by Ionizing Radiation

  1998cites this paper
• The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell‐cycle‐inhibitory function induces tumorigenesis

  1998cites this paper
• Posttranslational Mechanisms Leading to Mammalian Gene Activation in Response to Genotoxic Stress

  1998cites this paper
• Apoptotic response of spermatogenic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane

  1998cites this paper
• Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.

  1998cites this paper
• MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells.

  1998cites this paper
• Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

  1998cites this paper
• Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms

  1997cites this paper
• Csa-19, a radiation-responsive human gene, identified by an unbiased two-gel cDNA library screening method in human cancer cells

  1997cites this paper
• MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells.

  1997cites this paper
• Stress Responses in Drosophila Cells

  1997cites this paper
• Type of inducing signal regulates transactivation by p53.

  1997cites this paper
• The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress.

  1997cites this paper
• Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells.

  1997cites this paper
• The genetic defect in ataxia-telangiectasia.

  1997cites this paper
• The MDM2 C-terminal Region Binds to TAFII250 and Is Required for MDM2 Regulation of the Cyclin A Promoter*

  1997cites this paper
• Modulation of (±)-anti-BPDE mediated p53 accumulation by inhibitors of protein kinase C and poly(ADP-ribose) polymerase

  1997cites this paper
• The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair.

  1997cites this paper
• P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.

  1997cites this paper
• In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation

  1997cites this paper
• Human recombinant interferon alpha-2a plus 3'-azido-3'-deoxythymidine. Synergistic growth inhibition with evidence of impaired DNA repair in human colon adenocarcinoma cells.

  1997cites this paper
• Mdm‐2: “big brother” of p53

  1997cites this paper
• p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON‐HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONS

  1997cites this paper
• Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?

  1997cites this paper
• Mdm2: keeping p53 under control

  1997cites this paper
• Induction of Mdm2 and enhancement of cell survival by bFGF

  1997cites this paper
• Abrogation of G1 arrest after DNA damage is associated with constitutive overexpression of Mdm2, Cdk4, and Irf1 mRNAs in the BALB/c 3T3 A31 variant 1-1 clone.

  1997cites this paper
• A polymorphism but no mutations in the GADD45 gene in breast cancers

  1996cites this paper
• Adenovirus E1A proteins inhibit activation of transcription by p53

  1996influential citation
• p53 in growth control and neoplasia.

  1996cites this paper
• Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation*

  1996cites this paper
• p53: DNA damage, DNA repair, and apoptosis.

  1996cites this paper
• A MOLECULAR AND IMMUNOHISTOCHEMICAL STUDY OF THE MDM2 PROTEIN ISOFORMS AND p53 GENE PRODUCT IN BRONCHOGENIC CARCINOMA

  1996cites this paper
• Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway.

  1996cites this paper
• Induction of inositol 1,4,5 trisphosphate receptor genes by ionizing radiation.

  1996cites this paper
• Chlorambucil in chronic lymphocytic leukemia: mechanism of action.

  1996cites this paper
• p53 mutations in non-small cell lung carcinomas in Hong Kong.

  1996cites this paper
• Regulation of the cell cycle following DNA damage in normal and Ataxia telangiectasia cells

  1996cites this paper
• The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.

  1996cites this paper
• Cell type‐specific inhibition of p53‐mediated apoptosis by mdm2.

  1996cites this paper
• Alterations in p53 do not correlate with radioresistant DNA synthesis.

  1996cites this paper
• Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.

  1996cites this paper
• Chemotherapeutic drug cytotoxicity enhancement in human cells in culture

  1996cites this paper
• Immunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines.

  1995cites this paper
• Use of semiquantitative reverse transcription-polymerase chain reaction to study gene expression in normal human skin fibroblasts following low dose-rate irradiation.

  1995cites this paper
• Molecular biologic features of non-small cell lung cancer. Clinical implications.

  1995cites this paper
• P53, cell cycle control and apoptosis: Implications for cancer

  1995cites this paper
• Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.

  1995cites this paper
• Applications of molecular biology to biomedicine and toxicology

  1995cites this paper
• Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest.

  1995cites this paper
• Inhibition of poly(ADP-ribose) polymerase increases (+/-)-anti-benzo [a]pyrene diolepoxide-induced micronuclei formation and p53 accumulation in isolated human peripheral blood lymphocytes.

  1995cites this paper
• Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.

  1995cites this paper
• Status of the mdm-2 and waf-1 genes in mouse epidermal jb6 variants harboring wild-type p53 - a p53-independent induction of waf-1.

  1995cites this paper
• Relation between benzo[a]pyrene-DNA adducts, cell proliferation and p53 expression in tracheal epithelium of hamsters fed a high beta-carotene diet.

  1995cites this paper
• MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis.

  1995cites this paper
• p53: a cell cycle regulator activated by DNA damage.

  1995cites this paper
• Expression of the protooncogene mdm2 markedly increases in response to carbon tetrachloride but not after partial hepatectomy in contrast to p53.

  1995cites this paper
• c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.

  1995cites this paper
• Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.

  1995cites this paper
• Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.

  1995cites this paper
• Altered patterns of MDM2 and TP53 expression in human bladder cancer.

  1994cites this paper
• p53 and the Li-Fraumeni syndrome.

  1994cites this paper
• The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.

  1994influential citation
• Programmed cell death — many questions still to be answered

  1994cites this paper
• Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease.

  1994cites this paper